Loading clinical trials...
Loading clinical trials...
Evaluation of the Efficacy of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis: Randomized Double-blind Placebo-controlled Trial
Conditions
Interventions
Anti-tumor necrosis factor alpha monoclonal antibody
placebo
Locations
1
France
Hospital of necker Enfants malades
Paris, France
Start Date
June 29, 2011
Primary Completion Date
November 4, 2014
Completion Date
August 27, 2015
Last Updated
September 8, 2025
NCT07218770
NCT05486468
NCT02706704
NCT06431373
NCT07262437
NCT07176130
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions